Avanos Medical, Inc.

Historical 13F Holders

Symbol
AVNS
CUSIP
05350V106
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 274 43.4 M $623 M
2024 Q4 259 43.2 M $688 M
2024 Q3 262 42.9 M $1.03 B
2024 Q2 264 42.8 M $853 M
2024 Q1 269 44.6 M $888 M
2023 Q4 272 45.3 M $1.02 B
2023 Q3 266 43.7 M $884 M
2023 Q2 280 44.4 M $1.13 B
2023 Q1 293 44.1 M $1.31 B
2022 Q4 294 45.5 M $1.23 B
2022 Q3 276 43.5 M $949 M
2022 Q2 290 43.4 M $1.19 B
2022 Q1 305 44.1 M $1.48 B
2021 Q4 302 44.0 M $1.52 B
2021 Q3 276 43.7 M $1.36 B
2021 Q2 280 44.5 M $1.62 B
2021 Q1 295 44.2 M $1.93 B
2020 Q4 286 47.4 M $2.17 B
2020 Q3 284 46.0 M $1.53 B
2020 Q2 288 46.4 M $1.36 B
2020 Q1 285 47.3 M $1.27 B
2019 Q4 303 46.6 M $1.57 B
2019 Q3 299 45.3 M $1.70 B
2019 Q2 334 47.9 M $2.09 B
2019 Q1 354 45.3 M $1.93 B
2018 Q4 361 44.5 M $2.00 B
2018 Q3 403 43.9 M $3.01 B
2018 Q2 38 1.04 M $59.6 M
2018 Q1 2 332 $15.3 k
2017 Q4 2 319 $14.7 k
2017 Q3 2 319 $14.4 k
2017 Q2 3 347 $13.6 k
2017 Q1 3 347 $13.2 k
2016 Q4 3 359 $13.3 k
2016 Q3 2 432 $15.0 k
2016 Q2 2 479 $15.6 k
2016 Q1 3 611 $19.8 k